Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2006-000859-18-DE
EUCTR2006-000859-18-DEActive, not recruitingNot Applicable

An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer study

Solvay pharmaceuticals0 sites225 target enrollmentStarted: April 5, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
225
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •- Subjects who have signed informed consent for participation in the extension study.
  • •- Subjects who have completed the S308.3.003 trial.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •1. Subjects with medically relevant abnormal findings (electrocardiogram [ECG], physical examination, AEs) at end of the maintenance phase (Visit M6, Week 24) of study S308.3.003.

Investigators

Similar Trials

Active, not recruiting
Not Applicable
An open label SLV308 safety extension to study S308.3.002 in patients with Parkinson’s disease experiencing motor fluctuations. - An extension of the Mondrian studyAdvanced stage Parkinson's disease with motor fluctuations.MedDRA version: 9.1Level: LLTClassification code 10013113Term: Disease Parkinson's
EUCTR2006-005183-91-LTSolvay Pharmaceuticals220
Active, not recruiting
Not Applicable
An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer studyParkinson's Disease Early stage
EUCTR2006-000859-18-CZSolvay Pharmaceuticals225
Active, not recruiting
Phase 1
An open label SLV308 safety extension to study S308.3.001 in early PD patients. - An extension of the Rembrandt studyParkinson's Disease Early Stage
EUCTR2006-000858-45-SKSolvay Pharmaceuticals300
Active, not recruiting
Not Applicable
An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer studyParkinson's Disease Early stage
EUCTR2006-000859-18-NLSolvay pharmaceuticals247
Active, not recruiting
Not Applicable
An open label SLV308 safety extension to study S308.3.001 in early PD patients. - An extension of the Rembrandt studyParkinson's Disease Early Stage
EUCTR2006-000858-45-SESolvay Pharmaceuticals300